Abnormal activation of NLRP3 inflammasomes has recently been found in various cancer types; however, the role of NLRP3 inflammasomes in 5-FU chemoresistance of CRC cells has not been clearly elucidated. The gene discussed is NLRP3; the disease is colorectal carcinoma.